Gershenson DM - Search Results

1

Treatment of Rare Epithelial Ovarian Tumors.

Cobb LP, Gershenson DM. Cobb LP, et al. Among authors: gershenson dm. Hematol Oncol Clin North Am. 2018 Dec;32(6):1011-1024. doi: 10.1016/j.hoc.2018.07.015. Hematol Oncol Clin North Am. 2018. PMID: 30390757 Review.

2

The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered.

Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Kavanagh JJ, Morris M, Burke TW, Warner D, Wharton JT. Gershenson DM, et al. Gynecol Oncol. 1992 Oct;47(1):7-13. doi: 10.1016/0090-8258(92)90067-s. Gynecol Oncol. 1992. PMID: 1427404 Clinical Trial.

3

Choroidal metastasis from primary ovarian carcinoma.

Grendys EC, Tang RA, Gershenson DM. Grendys EC, et al. Among authors: gershenson dm. Gynecol Oncol. 1992 Aug;46(2):251-4. doi: 10.1016/0090-8258(92)90266-l. Gynecol Oncol. 1992. PMID: 1500031 No abstract available.

4

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).

Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JT. Levenback C, et al. Among authors: gershenson dm. Gynecol Oncol. 1992 Sep;46(3):317-21. doi: 10.1016/0090-8258(92)90224-7. Gynecol Oncol. 1992. PMID: 1526508

5

Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.

Jacob JH, Gershenson DM, Morris M, Copeland LJ, Burke TW, Wharton JT. Jacob JH, et al. Among authors: gershenson dm. Gynecol Oncol. 1991 Aug;42(2):146-50. doi: 10.1016/0090-8258(91)90335-3. Gynecol Oncol. 1991. PMID: 1894174

6

Serous ovarian tumors of low malignant potential with peritoneal implants.

Gershenson DM, Silva EG. Gershenson DM, et al. Cancer. 1990 Feb 1;65(3):578-85. doi: 10.1002/1097-0142(19900201)65:3<578::aid-cncr2820650332>3.0.co;2-n. Cancer. 1990. PMID: 2297647

7

Ovarian carcinomas with transitional cell carcinoma pattern.

Silva EG, Robey-Cafferty SS, Smith TL, Gershenson DM. Silva EG, et al. Among authors: gershenson dm. Am J Clin Pathol. 1990 Apr;93(4):457-65. doi: 10.1093/ajcp/93.4.457. Am J Clin Pathol. 1990. PMID: 2321577

8

Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy.

Robey SS, Silva EG, Gershenson DM, McLemore D, el-Naggar A, Ordonez NG. Robey SS, et al. Among authors: gershenson dm. Cancer. 1989 Mar 1;63(5):839-47. doi: 10.1002/1097-0142(19890301)63:5<839::aid-cncr2820630508>3.0.co;2-u. Cancer. 1989. PMID: 2644014

9

Secondary cytoreductive surgery in epithelial ovarian cancer: nonresponders to first-line therapy.

Morris M, Gershenson DM, Wharton JT. Morris M, et al. Among authors: gershenson dm. Gynecol Oncol. 1989 Apr;33(1):1-5. doi: 10.1016/0090-8258(89)90593-3. Gynecol Oncol. 1989. PMID: 2703158

10

Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy.

Gershenson DM, Kavanagh JJ, Copeland LJ, Stringer CA, Morris M, Wharton JT. Gershenson DM, et al. Obstet Gynecol. 1989 May;73(5 Pt 1):798-802. Obstet Gynecol. 1989. PMID: 2704508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

509 results

Search Page